The BET inhibitor JQ1 inhibited mRNA and protein expression of the RNA-binding protein IGF2BP3 in Ewing sarcoma and B cell acute lymphoblastic leukemia [244,245]. Here, IGF2BP3 is linked to B-cell acute lymphoblastic leukemia.